Impact of Government Policies and Proposals on Community Oncologists

The federal government has been releasing a number of policies and proposals that will affect care delivery and are aimed at rising costs of care and prescription drugs.

The federal government has been releasing a number of policies and proposals that will affect care delivery and are aimed at rising costs of care and prescription drugs.

Ted Okon, executive director of the Community Oncology Alliance (COA), sat down with Managed Care Cast to discuss a number of policies affecting COA’s members, including proposals around chimeric antigen receptor T-cell therapies, pharmacy benefit managers, and the Oncology Care Model.

You may need to log in to the website to access this podcast.

iTunes

TuneIn

Stitcher

Spotify

Listen above or through one of these podcast services:

CMS Proposes That Patients Be Enrolled in Studies to Get Coverage for CAR T-Cell Therapy

Ted Okon on Policy Priorities for COA in 2019

COA's OCM 2.0: Moving Toward a Universal Payment Model

More Than 300 Groups Seek Halt to CMS' Plans for Global Drug Pricing Index

Trump Proposes Allowing Medicare to Base Drug Prices on What Other Countries Pay

HHS Proposes to End Drug Rebates in Medicare, Medicaid Managed Care

Read more about the stories in this podcast: